TendoNova
PrivateLast Round
Debt
Jun 26, 2024
Total Funding Raised
$520,000
Company Overview
TendoNova is a medical device company that develops and commercializes micro-invasive tools for orthopedic procedures, such as the FDA-cleared Ocelot system for treating chronic tendon pain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TendoNova Comps
Public and private peers based on sector, stage, and business model.
TendoNova Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 26, 2024 | ||||
| VC Round | Apr 12, 2024 | ||||
| Grant | Aug 5, 2021 | ||||
| Seed | Jun 11, 2020 |
TendoNova Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Georgia Research Alliance | Seed, Grant |
| NFL Players Association | Seed |
| VentureSouth | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 24, 2026
Medical device has received FDA clearance.
TendoNova Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TendoNova's valuation, stock price, and market status.
